Victor R. Gordeuk

Hematology
1740 W Taylor St
Chicago, IL 60612

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 231 publications

When endurance running leads to functional iron deficiency.

When endurance running leads to functional iron deficiency.

Journal: Blood advances
Published: August 28, 2026

Sustainment of Hydroxyurea Adherence in Patients With Sickle Cell Disease.

Sustainment of Hydroxyurea Adherence in Patients With Sickle Cell Disease.

Journal: JAMA network open
Published: May 06, 2026

Local ancestry-aware genome-wide meta-analysis uncovers novel genetic loci for sickle cell disease nephropathy.

Local ancestry-aware genome-wide meta-analysis uncovers novel genetic loci for sickle cell disease nephropathy.

Journal: Blood advances
Published: April 24, 2026

Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange (SCD-CARRE) trial.

Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange (SCD-CARRE) trial.

Journal: American heart journal
Published: April 16, 2026

The CYB5R3 T117S Missense Variant is Associated with Attenuated Riociguat Efficacy in Sickle Cell Disease.

The CYB5R3 T117S Missense Variant is Associated with Attenuated Riociguat Efficacy in Sickle Cell Disease.

Journal: Blood
Published: March 31, 2026

Shunting for Idiopathic Normal-Pressure Hydrocephalus.

Shunting for Idiopathic Normal-Pressure Hydrocephalus.

Journal: The New England journal of medicine
Published: March 04, 2026

Impact of voxelotor discontinuation on patients with sickle cell disease.

Impact of voxelotor discontinuation on patients with sickle cell disease.

Journal: British journal of haematology
Published: March 04, 2026

Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell Disease.

Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell Disease.

Journal: Blood
Published: February 20, 2026

Renin-angiotensin-aldosterone system inhibition exacerbates anemia in sickle cell disease.

Renin-angiotensin-aldosterone system inhibition exacerbates anemia in sickle cell disease.

Journal: Blood
Published: February 20, 2026

Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease.

Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease.

Journal: British journal of haematology
Published: January 12, 2026

Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemia.

Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemia.

Journal: Haematologica
Published: October 21, 2025

VHL, transferrin, and erythropoietin in the regulation of hepcidin.

VHL, transferrin, and erythropoietin in the regulation of hepcidin.

Journal: HemaSphere
Published: September 11, 2025
Showing 1-12 of 231

Last Updated: 09/26/2026